Evidence map›Paper›PMID 38224449›Full record

ReviewNucleic acids research2024

To kill a microRNA: emerging concepts in target-directed microRNA degradation.

Amber F Buhagiar, Benjamin Kleaveland

Open access · goldAbstract readReview
In one paragraph

Review in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genes & development · 2026
    Article
  8. bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Target-Directed miRNA Degradation: Mechanisms and Significance.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amber F BuhagiarDepartment of Pathology and Lab Medicine, Weill Cornell Medicine, New York, NY10065, USA.ORCID 0000-0002-3095-2921
Benjamin KleavelandDepartment of Pathology and Lab Medicine, Weill Cornell Medicine, New York, NY10065, USA.ORCID 0000-0002-0333-3586
Cornell University · US

Funding

Destruction of noncoding RNAs - R35 Diversity SupplementR35GM147463 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BENJAMIN MONTEVERDE KLEAVELAND · 2022 to 2026
$2.3M
NIGMS NIH HHS R35 GM147463NIGMS NIH HHS R35GM147463
6 · The paper itself

Abstract

MicroRNAs (miRNAs) guide Argonaute (AGO) proteins to bind mRNA targets. Although most targets are destabilized by miRNA-AGO binding, some targets induce degradation of the miRNA instead. These special targets are also referred to as trigger RNAs. All triggers identified thus far have binding sites with greater complementarity to the miRNA than typical target sites. Target-directed miRNA degradation (TDMD) occurs when trigger RNAs bind the miRNA-AGO complex and recruit the ZSWIM8 E3 ubiquitin ligase, leading to AGO ubiquitination and proteolysis and subsequent miRNA destruction. More than 100 different miRNAs are regulated by ZSWIM8 in bilaterian animals, and hundreds of trigger RNAs have been predicted computationally. Disruption of individual trigger RNAs or ZSWIM8 has uncovered important developmental and physiologic roles for TDMD across a variety of model organisms and cell types. In this review, we highlight recent progress in understanding the mechanistic basis and functions of TDMD, describe common features of trigger RNAs, outline best practices for validating trigger RNAs, and discuss outstanding questions in the field.

Indexed as

MicroRNAsRNA StabilityAnimalsArgonaute ProteinsBinding SitesProteolysisUbiquitinationArgonaute ProteinsMicroRNAs

Identifiers

PMID38224449
PMCPMC10899785
OpenAlexW4390889305

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.